Last Updated:
Shares of Inventurus Knowledge Solutions listed with a premium of practically 43 per cent in opposition to the problem value of Rs 1,329 on Thursday.
Inventurus Knowledge Solutions Share Price: Opened at Rs 1,856, marking a 39.65% rally from the problem value, and later surged 46.13% to Rs 1,942.10.
Shares of Inventurus Knowledge Solutions Ltd, a supplier of healthcare help providers, made a formidable debut on Thursday, itemizing with a 43% premium over the problem value of Rs 1,329.
Inventurus Knowledge Solutions Share Price Today
Stock Performance on Listing Day
- BSE Listing: Opened at Rs 1,856, marking a 39.65% rally from the problem value, and later surged 46.13% to Rs 1,942.10.
- NSE Listing: Debuted at Rs 1,900, reflecting a 42.96% bounce.
- Market Valuation: The firm’s market cap reached Rs 32,282.35 crore.
IPO Details and Strong Subscription
- Issue Size: Rs 2,498 crore.
- Price Band: Rs 1,265-1,329 per share.
- Subscription: The IPO obtained 52.68 instances subscription on its closing day.
- Offer For Sale (OFS): The IPO was totally an OFS of 1.88 crore fairness shares by promoters and particular person shareholders, with no recent difficulty part.
- Proceeds: As the problem was totally an OFS, the corporate is not going to obtain any proceeds, and your complete quantity will go to the promoting shareholders.
Objectives Behind the IPO
Inventurus Knowledge Solutions acknowledged in its IPO paperwork that the first goals of the share sale have been:
- Gaining benefits of itemizing fairness shares on inventory exchanges.
- Enhancing visibility and model picture.
- Providing liquidity to current shareholders.
- Establishing a public marketplace for its fairness shares.
About Inventurus Knowledge Solutions
Inventurus Knowledge Solutions Ltd is a technology-enabled healthcare options supplier targeted on care enablement. The firm assists doctor enterprises primarily within the US, Canada, and Australia, with a robust emphasis on the US market.
Client Base: Serves over 800 healthcare organisations, together with well being programs, tutorial medical centres, multi-specialty and single-specialty medical teams, in addition to ancillary healthcare organisations.
Backers: The firm is supported by Rekha Jhunjhunwala and RARE Enterprises.
The robust market debut underscores investor confidence within the firm’s healthcare-centric options and its progress potential in worldwide markets.
